Zobrazeno 1 - 10
of 390
pro vyhledávání: '"Mitsuhiko Moriyama"'
Autor:
Mitsuhiko Moriyama, Tatsuo Kanda, Yutaka Midorikawa, Hiroshi Matsumura, Ryota Masuzaki, Hitomi Nakamura, Masahiro Ogawa, Shunichi Matsuoka, Toshikatu Shibata, Motomi Yamazaki, Kazumichi Kuroda, Hisashi Nakayama, Tokio Higaki, Kazunori Kanemaru, Toshio Miki, Masahiko Sugitani, Tadatoshi Takayama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-21 (2022)
Abstract Recently, we reported that extent of proliferation of atypical hepatocytes (atypical hepatocytes) was most important histological risk factor for development of hepatocellular carcinoma (HCC) from chronic hepatitis C or liver cirrhosis. Here
Externí odkaz:
https://doaj.org/article/27e6f2d8468c4fb0b2d055a0dbb1b956
Autor:
Maho Iwamoto, Tsugumichi Koshinaga, Eri Fujita, Manabu Hanada, Shuichiro Uehara, Mitsuhiko Moriyama
Publikováno v:
BMC Pediatrics, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Anastomotic or perianastomotic ulcers present with symptoms such as chronic anaemia and occult bleeding as long-term complications of bowel resection performed in infancy. Case presentation Herein, we describe a 15-year-old girl w
Externí odkaz:
https://doaj.org/article/4d640c1851584407ac370b25160c55e9
Autor:
Reina Sasaki-Tanaka, Toshikatsu Shibata, Mitsuhiko Moriyama, Hirofumi Kogure, Asuka Hirai-Yuki, Hiroaki Okamoto, Tatsuo Kanda
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9708 (2023)
The hepatitis A virus (HAV) infection causes acute hepatitis. HAV also induces acute liver failure or acute-on-chronic liver failure; however, no potent anti-HAV drugs are currently available in clinical situations. For anti-HAV drug screening, more
Externí odkaz:
https://doaj.org/article/2f1e0ef5a2d14cd083b9ff621ce5c65e
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6471 (2023)
In this Special Issue, “Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy”, of the International Journal of Molecular Sciences, a total of 10 impactful articles have been published [...]
Externí odkaz:
https://doaj.org/article/dce0357898d44198a645623d6a893a09
Autor:
Shinya Asatani, Tatsuo Kanda, Masayuki Honda, Tomotaka Ishii, Yoichiro Yamana, Tomohiro Kaneko, Taku Mizutani, Hiroshi Takahashi, Mariko Kumagawa, Reina Sasaki, Ryota Masuzaki, Shini Kanezawa, Naoki Matsumoto, Kazushige Nirei, Hiroaki Yamagami, Mitsuhiko Moriyama
Publikováno v:
JGH Open, Vol 5, Iss 6, Pp 722-724 (2021)
Abstract Recently, the use of immune checkpoint inhibitors (ICIs) with or without chemotherapeutic agents has been increasing in the treatment for advanced cancer. Here, we report the occurrence of liver failure after the use of pembrolizumab in an 8
Externí odkaz:
https://doaj.org/article/f4f5f2730d6b46a5bf1f52d3e4ac0627
Autor:
Shini Kanezawa, Mitsuhiko Moriyama, Tatsuo Kanda, Akiko Fukushima, Ryota Masuzaki, Reina Sasaki-Tanaka, Akiko Tsunemi, Takahiro Ueno, Noboru Fukuda, Hirofumi Kogure
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4603 (2023)
Metabolic-dysfunction-associated fatty-liver disease (MAFLD) is the principal worldwide cause of liver disease. Individuals with nonalcoholic steatohepatitis (NASH) have a higher prevalence of small-intestinal bacterial overgrowth (SIBO). We examined
Externí odkaz:
https://doaj.org/article/04a70fb8fc8540c0b61bdd97322acce4
Autor:
Yukinobu Watanabe MD, PhD, Masahiro Ogawa MD, PhD, Yu Tamura MD, Seiichiro Suda MD, Masahiro Kaneko MD, Mariko Kumagawa MD, Midori Hirayama MD, Naoki Matsumoto MD, PhD, Toshiki Yamamoto MD, PhD, Mitsuhiko Moriyama MD, PhD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
A 74-year-old man was diagnosed with hepatocellular carcinoma. The tumor in the liver showed a complete response after transcatheter arterial chemoembolization, but lung, bone, and lymph node metastases were observed, so treatment with atezolizumab p
Externí odkaz:
https://doaj.org/article/783b9584d7a640a6921799fd32804d6c
Autor:
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Prior hepatitis B virus infection (PBI) may increase the risk of developing hepatocellular carcinoma (HCC), but the impact of PBI on clinical outcomes following treatment for HCC remains unknown. The aim of this study was to clari
Externí odkaz:
https://doaj.org/article/b557d7695cce46f680249677bc49503a
Autor:
Hiroshi Nakagawara, Kenji Yamao, Takuji Gotoda, Daiichiro Kikuta, Akinori Takei, Kunio Iwatsuka, Toshimi Takahashi, Masahiro Ogawa, Akihiro Henmi, Makio Kobayashi, Mitsuhiko Moriyama
Publikováno v:
International Journal of Gastrointestinal Intervention, Vol 8, Iss 2, Pp 82-86 (2019)
Background : Endoscopic-guided placement of metal stents for unresectable malignant hilar biliary obstruction (UMHBO) is performed using partial stent-in-stent or side-by-side (SBS) techniques. The latter involves placing sequential stents within the
Externí odkaz:
https://doaj.org/article/12c48bb759354f39b0167e5c60a6d908
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 17, p 9679 (2022)
Alcohol is the one of the major causes of liver diseases and promotes liver cirrhosis and hepatocellular carcinoma (HCC). In hepatocytes, alcohol is converted to acetaldehyde, which causes hepatic steatosis, cellular apoptosis, endoplasmic reticulum
Externí odkaz:
https://doaj.org/article/2d8e8c61bc29473083d3b013f71592cb